These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29189377)

  • 21. Imaging in Autoimmune Pancreatitis and Immunoglobulin G4-Related Disease of the Abdomen.
    Sandrasegaran K; Menias CO
    Gastroenterol Clin North Am; 2018 Sep; 47(3):603-619. PubMed ID: 30115440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].
    Voth M; Opfermann T; Gottschild D
    Zentralbl Chir; 2003 May; 128(5):375-8. PubMed ID: 12813634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT.
    Luo Y; Pan Q; Zhang W; Li F
    Clin Nucl Med; 2020 Apr; 45(4):310-311. PubMed ID: 31977474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET/CT Imaging of Pancreatic Plasmacytoma.
    Huang WS; Zheng Y; Chen JW; Zhang GX; Xu JH
    Clin Nucl Med; 2020 Jun; 45(6):489-491. PubMed ID: 32349089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis.
    Kato K; Nihashi T; Ikeda M; Abe S; Iwano S; Itoh S; Shimamoto K; Naganawa S
    Clin Nucl Med; 2013 Jun; 38(6):417-21. PubMed ID: 23486318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of FDG PET/CT in IgG4-related systemic disease.
    Nakatani K; Nakamoto Y; Togashi K
    Clin Radiol; 2012 Apr; 67(4):297-305. PubMed ID: 22119099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis.
    Sato M; Okumura T; Shioyama Y; Imura J
    Ann Nucl Med; 2008 Apr; 22(3):215-9. PubMed ID: 18498037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin G4, autoimmune pancreatitis and pancreatic cancer.
    Bojková M; Dítě P; Dvořáčková J; Novotný I; Floreánová K; Kianička B; Uvírová M; Martínek A
    Dig Dis; 2015; 33(1):86-90. PubMed ID: 25531501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?
    Nitzsche EU; Hoegerle S; Mix M; Brink I; Otte A; Moser E; Imdahl A
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):237-42. PubMed ID: 11926386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic Malignancy or Not?: Role of 18F-FDG PET/CT in Solving the Diagnostic Dilemma and Evaluating Treatment Response.
    Parihar AS; Singh H; Kumar R; Gupta V; Singh H; Mittal BR
    Clin Nucl Med; 2018 Apr; 43(4):e115-e117. PubMed ID: 29401142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune pancreatitis: a challenging diagnostic puzzle for clinicians.
    Buscarini E; Frulloni L; De Lisi S; Falconi M; Testoni PA; Zambelli A
    Dig Liver Dis; 2010 Feb; 42(2):92-8. PubMed ID: 19805009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of contrast-enhanced harmonic EUS for evaluating the effects of steroid therapy in a case of immunoglobulin G4-negative focal autoimmune pancreatitis.
    Kamata K; Takenaka M; Minaga K; Kudo M
    Gastrointest Endosc; 2017 Dec; 86(6):1177-1179. PubMed ID: 28673642
    [No Abstract]   [Full Text] [Related]  

  • 35. A fare case of pancreatic metastasis from malignant melanoma mimicking pancreatitis on
    Filippi L; Proietti I; Schillaci O; Potenza C; Bagni O
    J Egypt Natl Canc Inst; 2021 Oct; 33(1):29. PubMed ID: 34632554
    [No Abstract]   [Full Text] [Related]  

  • 36. FDG-PET/CT findings of autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis.
    Otsuka H; Morita N; Yamashita K; Nishitani H
    Ann Nucl Med; 2007 Dec; 21(10):593-6. PubMed ID: 18092136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
    Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
    Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG PET/CT in autoimmune pancreatitis.
    Nanni C; Romagnoli R; Rambaldi I; Caroli P; Matteucci F; Ambrosini V; Re G; Fanti S
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1264-5. PubMed ID: 24562645
    [No Abstract]   [Full Text] [Related]  

  • 39. [Autoimmune pancreatitis--a rare and difficult differential diagnosis to pancreatic cancer].
    Breuer A; Benz SR; Enz T; Deubler G; Mörk H
    Med Klin (Munich); 2007 Feb; 102(2):157-62. PubMed ID: 17323023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions.
    Nakajo M; Jinnouchi S; Fukukura Y; Tanabe H; Tateno R; Nakajo M
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2088-95. PubMed ID: 17713765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.